HJL-10640-57654
2 vaccinations
1 coded response
5 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 604 / IL
- Registered
- 2021-03-06
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- N/A
Timeline
-
2021-03-01
Dose 1 — Pfizer-BioNTech
-
2021-03-06
Registered in v-safe
- 2021-03-06
- 2021-03-07
- 2021-03-08
-
2021-03-15
Survey response — day 14, dose 1MedDRA: Headache — Feeling: Fair · Be unable to workFree text: HeadacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-15
-
2021-03-22
Dose 2 — Pfizer-BioNTech
- 2021-04-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-01 | Pfizer-BioNTech | |
| 2 | 2021-03-22 | Pfizer-BioNTech |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 5 — day 14, dose 1
Symptoms: Headache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release